In anticipation of declining revenues for one of its top drugs, Pfizer, the world's biggest pharmaceutical company headquartered in New York, announced that it is open to acquisitions.
In anticipation of declining revenues for one of its top drugs, Pfizer, the world's biggest pharmaceutical company headquartered in New York, announced that it is open to acquisitions.